<DOC>
	<DOCNO>NCT01927393</DOCNO>
	<brief_summary>This randomize clinical trial study palliative care improve quality life symptom patient stage III-IV pancreatic ovarian cancer . Palliative therapy may help patient advanced pancreatic ovarian cancer live comfortably .</brief_summary>
	<brief_title>Palliative Care Improving Quality Life Symptoms Patients With Stage III-IV Pancreatic Ovarian Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . Test effect concurrent palliative care plan intervention ( PCPI ) overall quality life ( QOL ) symptom burden . II . Test effect concurrent PCPI anxiety depression . III . Test effect concurrent PCPI overall survival . IV . Test effect concurrent PCPI health care resource use . OUTLINE : Patients randomize 1 2 arm . ARM I : Patients undergo comprehensive physical , psychological , social , spiritual palliative care assessment . Patients also receive workbook cover physical psychological well-being social spiritual well-being , deliver 2 educational session . ARM II : Patients receive standard care plus attention comprise two telephone contact . After completion study , patient follow 1 , 3 , 6 month .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Neoplasms , Glandular Epithelial</mesh_term>
	<mesh_term>Germinoma</mesh_term>
	<criteria>Diagnosis pancreatic ovarian cancer Confirmed stage III IV disease Patients within one year initial diagnosis Able read understand Englishthis include patientreported outcome measure validate linguistically diverse population ; intent adapt test intervention future study linguistically diverse population Ability read and/or understand study protocol requirement , provide write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>